Fortress Biotech
FBIO
54 hedge funds and large institutions have $18.4M invested in Fortress Biotech in 2019 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 6 closing their positions.
100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 6
98% more capital invested
Capital invested by funds: $9.31M → $18.4M (+$9.09M)
10% more funds holding
Funds holding: 49 → 54 (+5)
8% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 12
0.01% more ownership
Funds ownership: 0.64% → 0.65% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$328K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$319K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$236K |
| 4 |
SAM
Shikiar Asset Management
New York
|
+$229K |
| 5 |
BlackRock
New York
|
+$195K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$249K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$167K |
| 3 |
PAM
PVG Asset Management
Golden,
Colorado
|
-$112K |
| 4 |
RA
Rational Advisors
Huntington,
New York
|
-$105K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$86.5K |
FBIO Hedge Fund Activity: Q4 2019 in Review
54 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q4 2019, worth a combined $18.4M — up 98% from $9.31M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new FBIO positions and 6 closed out — a net gain of 6 holders — while 13 added to existing stakes and 12 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $328K. The largest seller was Millennium Management, cutting an estimated $249K.
- 54 institutional investors held Fortress Biotech (FBIO) as of Q4 2019, up from 49 in Q3 2019.
- Funds reported $18.4M of Fortress Biotech stock for Q4 2019, up 98% quarter-over-quarter.
- 12 funds opened new Fortress Biotech positions in Q4 2019 and 6 closed out, a net change of +6 holders.
- The largest Fortress Biotech buyer in Q4 2019 was Renaissance Technologies, an estimated $328K added.
- The largest Fortress Biotech seller in Q4 2019 was Millennium Management, an estimated $249K sold.
Based on aggregated 13F filings for Q4 2019.